Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses

被引:113
作者
Posavad, CM
Koelle, DM
Shaughnessy, MF
Corey, L
机构
[1] UNIV WASHINGTON, DEPT LAB MED, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA
[3] FRED HUTCHINSON CANC RES CTR, PROGRAM INFECT DIS, SEATTLE, WA 98104 USA
关键词
D O I
10.1073/pnas.94.19.10289
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The specific mechanisms underlying the varied susceptibility of HIV-infected (HIV+) individuals to opportunistic infections (OI) are still incompletely understood, One hypothesis is that quantitative differences in specific T cell responses to a colonizing organism determine the development of an AIDS-defining OI, We evaluated this hypothesis for herpes simplex virus (HSV) infection, a common OI in HIVS patients, Using limiting dilution analyses, the frequency of HSV-specific CD8(+) cytotoxic T lymphocyte precursors (pCTL) and proliferative precursors were quantitated in peripheral blood mononuclear cells from 20 patients coinfected with HIV and HSV-2. The frequency of HSV-specific CD8(+) pCTL in HSV+HIV+ individuals was significantly lower than in HSV+HIV- individuals (1 in 77,000 vs, 1 in 6,000, P = .0005) and was not different than in HSV-HIV- individuals (1 in 100,000, P = .24), HIV+ patients who suffered more severe genital herpes recurrences had significantly lower HSV-specific CD8(+) pCTL frequencies than those patients with mild recurrences (1 in 170,000 vs, 1 in 26,000, P = .03), In contrast, no significant difference was seen in proliferative precursor frequencies between those patients with mild vs, severe genital herpes (1 in 3,800 vs, 1 in 6,600, P > .5). Quantitative differences in pCTL frequency to HSV appear to be the most important host factor influencing the frequency and severity of HSV reactivation in HIV+ patients, Studies to reconstitute such immunity, especially in people with acyclovir-resistant HSV, appear warranted.
引用
收藏
页码:10289 / 10294
页数:6
相关论文
共 30 条
[1]   INCREASED GENITAL SHEDDING OF HERPES-SIMPLEX VIRUS TYPE-2 IN HIV-SEROPOSITIVE WOMEN [J].
AUGENBRAUN, M ;
FELDMAN, J ;
CHIRGWIN, K ;
ZENILMAN, J ;
CLARKE, L ;
DEHOVITZ, J ;
LANDESMAN, S ;
MINKOFF, H .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (11) :845-847
[2]  
AUGENBRAUN MH, 1994, INFECT DIS CLIN N AM, V8, P439
[3]   PHENOTYPIC AND GENOTYPIC CHARACTERIZATION OF ACYCLOVIR-RESISTANT VARICELLA-ZOSTER VIRUSES ISOLATED FROM PERSONS WITH AIDS [J].
BOIVIN, G ;
EDELMAN, CK ;
PEDNEAULT, L ;
TALARICO, CL ;
BIRON, KK ;
BALFOUR, HH .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) :68-75
[4]   T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2 [J].
Carmack, MA ;
Yasukawa, LL ;
Chang, SY ;
Tran, C ;
Saldana, F ;
Arvin, AM ;
Prober, CG .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :899-906
[5]   T-CELL BLASTOGENIC RESPONSES TO TOXOPLASMA-GONDII TROPHOZOITES AMONG HIV-INFECTED PATIENTS [J].
CARREGA, G ;
CANESSA, A ;
ARGENTA, P ;
CRUCIANI, M ;
BASSETTI, D .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (06) :741-746
[6]   ENUMERATION OF VIRAL ANTIGEN-REACTIVE HELPER LYMPHOCYTES-T IN HUMAN PERIPHERAL-BLOOD BY LIMITING DILUTION FOR ANALYSIS OF VIRAL ANTIGEN-REACTIVE T-CELL POOLS IN VIRUS-SEROPOSITIVE AND VIRUS-SERONEGATIVE INDIVIDUALS .34. [J].
CLOUSE, KA ;
ADAMS, PW ;
OROSZ, CG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (10) :2316-2323
[7]   HERPES-SIMPLEX VIRUS RESISTANT TO ACYCLOVIR - A STUDY IN A TERTIARY CARE CENTER [J].
ENGLUND, JA ;
ZIMMERMAN, ME ;
SWIERKOSZ, EM ;
GOODMAN, JL ;
SCHOLL, DR ;
BALFOUR, HH .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :416-422
[8]   PREVALENCE OF ANTIBODIES TO HUMAN HERPESVIRUSES AND HEPATITIS-B VIRUS IN PATIENTS AT DIFFERENT STAGES OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION [J].
ENZENSBERGER, R ;
BRAUN, W ;
JULY, C ;
HELM, EB ;
DOERR, HW .
INFECTION, 1991, 19 (03) :140-145
[9]   ANTIBODY-LEVELS FOR CYTOMEGALOVIRUS, HERPES-SIMPLEX VIRUS, AND RUBELLA IN PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME [J].
HALBERT, SP ;
KIEFER, DJ ;
FRIEDMANKIEN, AE ;
POIESZ, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 23 (02) :318-321
[10]  
HERSH EM, 1985, CANCER RES, V45, P406